APA (7th ed.) Citation

P, B., D, F., SY, W., C, P., L, F., J, U., . . . M, M. (2025). Prognostic significance of PET/CT for CAR T cell therapy in relapsed/refractory multiple myeloma. HemaSphere, 9(6), e70159. https://doi.org/10.1002/hem3.70159

Chicago Style (17th ed.) Citation

P, Born, et al. "Prognostic Significance of PET/CT for CAR T Cell Therapy in Relapsed/refractory Multiple Myeloma." HemaSphere 9, no. 6 (2025): e70159. https://doi.org/10.1002/hem3.70159.

MLA (9th ed.) Citation

P, Born, et al. "Prognostic Significance of PET/CT for CAR T Cell Therapy in Relapsed/refractory Multiple Myeloma." HemaSphere, vol. 9, no. 6, 2025, p. e70159, https://doi.org/10.1002/hem3.70159.